EUVIMEDEUVIMED entdecken
Crossref

The Effects of Continuous Venovenous Hemofiltration on Immunosuppressive Drug concentrations in an Ex‐Vivo Model of the critically Ill Adult: (CITRIC) study

Lucy A Chumas iD, Steven C Wallis, Chandra Sumi, Mohd Hafiz Abdul-Aziz, Brett C McWhinney, Jacobus P J Ungerer, Fiona Coyer, Dwarakanathan Ranganathan, Jason A Roberts, Jayesh Dhanani

Artificial Organs · 2026-11 · 50 (11) · 1595-1604

DOI: 10.1111/aor.70211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 29.08.2026. Verfasst von Lucy A Chumas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Continuous Renal Replacement Therapy, Hemofiltration. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Royal Brisbane and Women's Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pharmacokinetics of immunosuppressive drugs during continuous kidney replacement therapy (CKRT) modalities such as continuous venovenous hemofiltration (CVVH) are poorly understood, yet these drugs are crucial for transplant and critically ill patients.

Methods

An ex vivo adult CVVH circuit with AN69ST membrane was established, using whole blood (WB) or blood‐crystalloid (BC) to simulate hypoproteinemia and anemia, across a range of ultrafiltration rates (UFR) (1000–4000 mL/h) and point‐of‐dilution. Study drugs (tacrolimus, ciclosporin, mycophenolic acid (MPA), hydrocortisone, and methylprednisolone) were administered at clinically relevant concentrations. Drug concentrations were quantified by ultra‐high‐performance liquid chromatography–tandem mass spectrometry, and sieving coefficient (Sc) and clearance (Cl) were calculated.

Results

Mean Sc and Cl were significantly higher for BC than WB: methylprednisolone (Sc: 0.44 vs. 0.19 p < 0.001; Cl: 17.31 mL/min vs. 6.99 mL/min p < 0.001), hydrocortisone (Sc: 0.20 vs. 0.09 p = 0.005; Cl: 7.12 mL/min vs. 3.15 mL/min p = 0.01), MPA (Sc: 0.05 vs. 0.02 p < 0.001; Cl: 1.83 mL/min vs. 0.71 mL/min p < 0.001), ciclosporin (Sc: 0.00 vs. 0.00 p = 0.008; Cl: 0.02 mL/min vs. 0.01 mL/min p = 0.004). Tacrolimus was undetectable in ultrafiltrate. Point‐of‐dilution had minimal effect, except at UFR 4000 mL/h where pre‐dilution increased MPA and methylprednisolone clearance.

Conclusions

Hydrocortisone and methylprednisolone were cleared by CVVH, while tacrolimus, ciclosporin, and MPA Cl were negligible or absent. Hypoproteinemia and anemia significantly increased drug Cl. These findings provide mechanistic insights and support the need for validation in clinical studies to guide dosing during CKRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunosuppressive AgentsContinuous Renal Replacement TherapyHemofiltrationHumansCritical IllnessHydrocortisoneCyclosporineMethylprednisoloneTacrolimusMycophenolic AcidAdult

Stichwörter der Autor:innen

hemofiltrationimmunosuppressionkidneyrenal replacement therapy

Substanzen

Immunosuppressive AgentsHydrocortisoneCyclosporineMethylprednisoloneTacrolimusMycophenolic Acid

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Faculty of Health Medicine and Behavioural Sciences, University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Department of Chemical Pathology, Pathology Queensland, Brisbane, Queensland, Australia.
  • Faculty of Medicine, School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia.
  • School of Nursing, Midwifery and Social Work, The University of Queensland, Brisbane, Queensland, Australia.
  • School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia.

ORCID-Profile: Lucy A Chumas

Förderung

  • Royal Brisbane and Women's Hospital Foundation

Zitieren

APA

Chumas, L. A., Wallis, S. C., Sumi, C., Abdul-Aziz, M. H., McWhinney, B. C., Ungerer, J. P. J., Coyer, F., Ranganathan, D., Roberts, J. A., & Dhanani, J. (2026). The Effects of Continuous Venovenous Hemofiltration on Immunosuppressive Drug concentrations in an Ex‐Vivo Model of the critically Ill Adult: (CITRIC) study. Artificial Organs, 50(11), 1595-1604. https://doi.org/10.1111/aor.70211

Vancouver

Chumas LA, Wallis SC, Sumi C, Abdul-Aziz MH, McWhinney BC, Ungerer JPJ, et al. The Effects of Continuous Venovenous Hemofiltration on Immunosuppressive Drug concentrations in an Ex‐Vivo Model of the critically Ill Adult: (CITRIC) study. Artificial Organs. 2026;50(11):1595-1604. doi:10.1111/aor.70211

BibTeX
@article{Chumas2026,
  author = {Chumas, Lucy A and Wallis, Steven C and Sumi, Chandra and Abdul-Aziz, Mohd Hafiz and McWhinney, Brett C and Ungerer, Jacobus P J and Coyer, Fiona and Ranganathan, Dwarakanathan and Roberts, Jason A and Dhanani, Jayesh},
  title = {The Effects of Continuous Venovenous Hemofiltration on Immunosuppressive Drug concentrations in an Ex‐Vivo Model of the critically Ill Adult: (CITRIC) study},
  journal = {Artificial Organs},
  year = {2026},
  volume = {50},
  number = {11},
  pages = {1595--1604},
  doi = {10.1111/aor.70211}
}
Kostenlos starten →